Related Experiment Video

Updated: May 31, 2026

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice
15:43

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice

Published on: March 17, 2014

Pneumocystis jirovecii colonization in chronic pulmonary disease

S Gutiérrez1, N Respaldiza, E Campano

  • 1Instituto de Biomedicina de Sevilla, Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, Seville, Spain. anisoguri@hotmail.com

Parasite (Paris, France)
|June 18, 2011
PubMed

Insights

Pneumocystis jirovecii colonization, detected in patients without pneumonia, may influence chronic lung diseases. This review explores its role in conditions like COPD, cystic fibrosis, and lung cancer.

Area of Science:

  • Medical Microbiology
  • Pulmonology
  • Immunology

Background:

  • Pneumocystis jirovecii typically causes pneumonia in immunocompromised individuals.
  • Low levels of Pneumocystis DNA detection in asymptomatic patients suggest colonization rather than active infection.
  • Pneumocystis elicits local and systemic host responses, as evidenced by animal and human studies.

Purpose of the Study:

  • To review the presence and potential role of Pneumocystis jirovecii colonization in various chronic pulmonary diseases.
  • To investigate the suggested involvement of Pneumocystis colonization in the pathophysiology and progression of chronic lung conditions.

Main Methods:

  • Literature review of studies investigating Pneumocystis jirovecii.
  • Analysis of findings related to Pneumocystis colonization in chronic pulmonary disease patient cohorts.
  • Synthesis of evidence regarding the host response to Pneumocystis in different lung pathologies.

Main Results:

  • Pneumocystis jirovecii colonization has been identified in patients with chronic pulmonary diseases.
  • Evidence suggests a potential link between Pneumocystis colonization and the progression of these diseases.
  • The specific impact of colonization on conditions such as COPD, ILDs, CF, and lung cancer requires further elucidation.

Conclusions:

  • Pneumocystis jirovecii colonization is a recognized phenomenon in chronic lung disease patients.
  • Further research is warranted to understand the clinical significance and pathogenic role of Pneumocystis colonization in these conditions.

More Related Videos

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

Microbiological Rapid On-Site Evaluation for Pulmonary Infectious Diseases03:22

Microbiological Rapid On-Site Evaluation for Pulmonary Infectious Diseases

Published on: March 1, 2024

Related Concept Videos

Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Obstructive Pulmonary Disease01:24

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations01:19

Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations

Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet cell...
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...